Diabetes Care, Vol 21, Issue 8 1266-1270, Copyright © 1998 by American Diabetes Association

ARTICLES

Reversion from type 2 diabetes to nondiabetic status. Influence of the 1997 American Diabetes Association criteria

JP Burke, SM Haffner, SP Gaskill, KL Williams and MP Stern
Department of Medicine, University of Texas Health Science Center at San Antonio 78284-7873, USA. burkej@uthscsa.edu

OBJECTIVE: To determine the incidence and the rate of reversion of type 2 diabetes to a nondiabetic status in the 7- to 8-year follow-up of the San Antonio Heart Study, and to determine the influence of the recent 1997 American Diabetes Association (ADA) criteria for diabetes on these rates. Individuals who revert have been problematic for those developing criteria for the diagnosis of type 2 diabetes. Few studies have addressed this issue using 1979 National Diabetes Data Group/1980 World Health Organization (WHO) criteria. RESEARCH DESIGN AND METHODS: We studied 3,682 Mexican-American and non-Hispanic white men and nonpregnant women who completed both the baseline and follow-up examination of the San Antonio Heart Study. Incidence and reversion rates were calculated using both the 1980 WHO and the 1997 ADA criteria. Risk factors for reversion were identified, and the best fitting model using multiple logistic regression was determined using both the 1980 WHO and the 1997 ADA criteria. RESULTS: Using the 1997 ADA criteria, the age-adjusted incidences of type 2 diabetes for Mexican-American men and women were 10.8 and 12.2%, respectively. For non-Hispanic white men and women, the age-adjusted incidence rates were 5.5 and 5.1%, respectively. Similar age-adjusted incidences were recorded using the 1980 WHO criteria. The reversion rate for individuals with type 2 diabetes was 11.5% using the 1980 WHO criteria and 12.5% using the 1997 ADA criteria. These rates were not significantly different. Numerous risk factors for reversion were identified. The best fitting model, after controlling for age, sex, and ethnicity, included baseline 2-h glucose level, baseline HDL cholesterol, and previous diagnosis of diabetes. The models were the same for both the 1980 WHO and the 1997 ADA criteria. CONCLUSIONS: There was no significant difference in the incidence or the reversion rates for diabetic subjects using either 1980 WHO or 1997 ADA criteria. In addition, the risk factors for reversion were very similar using either set of criteria. The revision of the ADA criteria did not have a significant influence on reversion in this study.
CiteULike    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				J C. Agwu Screening for type 2 diabetes mellitus in children and adolescents The British Journal of Diabetes & Vascular Disease, July 1, 2008; 8(4): 163 - 168. [Abstract] [PDF]

				S. Genuth and R. Kahn A Step Backward--or Is it Forward? Diabetes Care, June 1, 2008; 31(6): 1093 - 1096. [Full Text] [PDF]

				Expert Committee on the Diagnosis and Classificati Follow-up Report on the Diagnosis of Diabetes Mellitus Clin. Diabetes, April 1, 2004; 22(2): 71 - 79. [Full Text] [PDF]

				Follow-up Report on the Diagnosis of Diabetes Mellitus Diabetes Spectr, January 1, 2004; 17(1): 51 - 59. [Full Text] [PDF]

				The Expert Committee on the Diagnosis and Classifi Follow-up Report on the Diagnosis of Diabetes Mellitus Diabetes Care, November 1, 2003; 26(11): 3160 - 3167. [Full Text] [PDF]

				M. J. McNeely, E. J. Boyko, D. L. Leonetti, S. E. Kahn, and W. Y. Fujimoto Comparison of a Clinical Model, the Oral Glucose Tolerance Test, and Fasting Glucose for Prediction of Type 2 Diabetes Risk in Japanese Americans Diabetes Care, March 1, 2003; 26(3): 758 - 763. [Abstract] [Full Text] [PDF]

				R. Harris, K. Donahue, S. S. Rathore, P. Frame, S. H. Woolf, and K. N. Lohr Screening Adults for Type 2 Diabetes: A Review of the Evidence for the U.S. Preventive Services Task Force Ann Intern Med, February 4, 2003; 138(3): 215 - 229. [Abstract] [Full Text] [PDF]

				M. P. Stern, P. Fatehi, K. Williams, and S. M. Haffner Predicting Future Cardiovascular Disease: Do we need the oral glucose tolerance test? Diabetes Care, October 1, 2002; 25(10): 1851 - 1856. [Abstract] [Full Text] [PDF]

				W. Wang, E. T. Lee, R. Fabsitz, T. K. Welty, and B. V. Howard Using HbA1c to Improve Efficacy of the American Diabetes Association Fasting Plasma Glucose Criterion in Screening for New Type 2 Diabetes in American Indians: The Strong Heart Study Diabetes Care, August 1, 2002; 25(8): 1365 - 1370. [Abstract] [Full Text] [PDF]

				M. P. Stern, K. Williams, and S. M. Haffner Identification of Persons at High Risk for Type 2 Diabetes Mellitus: Do We Need the Oral Glucose Tolerance Test? Ann Intern Med, April 16, 2002; 136(8): 575 - 581. [Abstract] [Full Text] [PDF]

				E. Eschwege, M. A. Charles, D. Simon, N. Thibult, and B. Balkau Reproducibility of the Diagnosis of Diabetes Over a 30-Month Follow-Up: The Paris Prospective Study Diabetes Care, November 1, 2001; 24(11): 1941 - 1944. [Abstract] [Full Text] [PDF]

				R. S. Legro, A. R. Kunselman, W. C. Dodson, and A. Dunaif Prevalence and Predictors of Risk for Type 2 Diabetes Mellitus and Impaired Glucose Tolerance in Polycystic Ovary Syndrome: A Prospective, Controlled Study in 254 Affected Women J. Clin. Endocrinol. Metab., January 1, 1999; 84(1): 165 - 169. [Abstract] [Full Text]